¡°ÍâÑóÈ˲š±×ß½ø±±¾©»ùÒò×éÑо¿Ëù
¡¡¡¡8ÔÂ27ÈÕ£¬ÒÀÍÐÓÀÀû¼¯ÍÅ¡°ÍâÑóÈ˲Å×ß½ø¿ÆѧԺ¡±Ô˶¯£¬ÖпÆÔº±±¾©»ùÒò×éÑо¿ËùÔ¼Çëµ½ÂéÊ¡Àí¹¤Ñ§ÔºÂéÊ¡Àí¹¤-¹þ·ðÍŽᲩµÂÑо¿Ëù´ÔÀÖ²©Ê¿¡¢Äϵ¤Âó´óѧµ¤ÂóÌÇÄò²¡Ñо¿Ëù»Æºê¸Õ²©Ê¿¡¢ÈðÊ¿ÂåÉ£Áª°îÀí¹¤Ñ§ÔºÉÛÃ÷¸»²©Ê¿ºÍÂéÊ¡Àí¹¤´óѧÕÅÊýÒ»²©Ê¿¹²ËÄλÍâÑóѧÕßµ½ËùÂÃÐлá¼û£¬¸±Ëù³¤ÍõÀöƼ¡¢¿Æ¼¼Ëæ´¦³¤Îâ¼Ñåû¼°¿ÆÑÐÏîÄ¿×éÏà¹ØÖ°Ô±¼ÓÈë½Ó´ý¡£
¡¡¡¡´ÔÀÖ²©Ê¿×÷ÁËÌâΪ¡°New Insights of CRISPR-Cas9 System for Genome Engineering Application¡±µÄѧÊõ±¨¸æ£¬²ûÊÍÁËCRISPR-Cas9ϵͳÔÚ»ùÒò¹¤³ÌÁìÓòеÄÓ¦ÓÃÔ¶¾°£»»Æºê¸Õ²©Ê¿×÷ÁËÌâΪ¡°Characterization of cysteine post-translational modifications and related cross-talk in diabetes using a novel cysteine specific phosphonate adaptable tag¡±µÄѧÊõ±¨¸æ£¬ÏÈÈÝÁ˱í¹ÛÒÅ´«ÐÞÊÎÖаëë×°±Ëá·ÒëºóÐÞÊÎÔÚÌÇÄò²¡Ñо¿ÖеÄÓ¦Óã»ÉÛÃ÷¸»²©Ê¿×÷ÁËÌâΪ¡°Models and algorithms for comparative genomics¡±µÄѧÊõ±¨¸æ£¬·ÖÏíÁ˽ÏÁ¿»ùÒò×éѧеÄÄ£×ÓºÍËã·¨ÆÊÎö£¬ÕÅÊýÒ»²©Ê¿×÷ÁËÌâΪ¡°The TCA cycle in cyanobacteria and potential applications¡±µÄѧÊõ±¨¸æ£¬ÏêϸÏÈÈÝÁËÀ¶Ôåϸ¾úÖÐÈýôÈËáÑ»·ÏµÍ³¼°ÆäDZÔÚµÄÓ¦ÓüÛÖµ¡£
¡¡¡¡²Î»áÖ°Ô±¶Ô¼¸Î»Ñ§ÕßµÄÑо¿ÁìÓòÐËȤʮ×㣬¿í´ó¿ÆÑÐÖ°Ô±ºÍÑо¿Éú¾Í±¨¸æÄÚÈݾÙÐÐÁËÓÐÕë¶ÔÐÔµÄÌáÎʺͽ»Á÷¡£»áºó£¬ËùÄÚ¿ÆÑÐ×鳤ÓëÁÐλÀ´·ÃÖ°Ô±¾ÙÐÐÁËÉîÈëÅÊ̸£¬¾ÍÑо¿ÁìÓò¡¢¿ÆÑÐÏ£Íû¡¢Î´À´Ñо¿Æ«ÏòµÈ¸÷·½ÃæÎÊÌâ½»Á÷ÁËÒâ¼û£¬Ë«·½¾ÍÏà¹ØÎÊÌâÕö¿ªÁËÈÈÁÒÌÖÂÛ¡£ËæØʺó·ÃÖ°Ô±ÂÃÐÐÁ˲¿·ÖʵÑéÊÒ£¬²¢Ï£ÍûδÀ´ÄÜÓëÑо¿ËùÕö¿ª½øÒ»²½ÏàÖú½»Á÷¡£
¡¡¡¡¡°ÍâÑóÈ˲Å×ß½ø¿ÆѧԺ¡±Ô˶¯ÊÇÖпÆԺΪ½¨ÉèÓëÍâÑóÈ˲ŵÄÖ±½ÓÁªÂç»úÖÆ£¬ÎªÒý½øÍâÑóÓÅÒìÈ˲ÅÌṩ½»Á÷ÓëË«ÏòÑ¡ÔñµÄƽ̨£¬Ö¼ÔÚʵʱÏòÍâÑóÈ˲ÅÐû´«ÔºÉú³¤Ì¬ÊÆ¡¢Ö÷Òª¿Æ¼¼Ð§¹û¡¢Ö÷ÒªÈ˲ÅÕþ²ßºÍÈ˲ÅÐèÇóµÈÏà¹ØÐÅÏ¢£¬Îª½øÒ»²½ÎüÒýÍâÑóÈ˲ţ¬ÊµÏÖ¡°ÂÊ×æÏȲŸߵؽ¨É衱ÍýÏëµÓÚ¨Ò»¶¨»ù´¡¡£
¡¡¡¡»Æºê¸Õ²©Ê¿×÷±¨¸æ
¡¡¡¡ÉÛÃ÷¸»²©Ê¿×÷±¨¸æ
ÕÅÊýÒ»²©Ê¿×÷±¨¸æ